Is $5.5 billion justice—or just closure without accountability? In this powerful and deeply personal reflection, Rob Kent, Esq., President of Kent Strategic Advisors and former New York State drug policy official, examines the conclusion of the federal criminal case against Purdue Pharma. For policymakers, clinicians, and those impacted by the opioid crisis, Kent’s message is clear: financial penalties alone are not enough.